Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
4.020
+0.060 (1.52%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Phathom Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
275555523462596936
Upgrade
Market Cap Growth
6.22%6.22%13.23%-22.48%-36.35%22.51%
Upgrade
Enterprise Value
533740535464461758
Upgrade
Last Close Price
4.028.129.1311.2219.6733.22
Upgrade
PS Ratio
4.6010.05766.45---
Upgrade
PB Ratio
-1.08-2.19-7.18-6.178.254.82
Upgrade
P/TBV Ratio
----8.254.82
Upgrade
EV/Sales Ratio
9.6413.39785.10---
Upgrade
Debt / Equity Ratio
-2.19-2.19-6.13-2.761.270.25
Upgrade
Asset Turnover
0.140.140.00---
Upgrade
Inventory Turnover
3.613.61----
Upgrade
Quick Ratio
3.923.929.885.929.695.18
Upgrade
Current Ratio
4.204.2010.256.129.865.25
Upgrade
Return on Equity (ROE)
-----108.01%-61.14%
Upgrade
Return on Assets (ROA)
-43.78%-43.78%-36.14%-60.85%-34.85%-28.44%
Upgrade
Return on Capital (ROIC)
-51.42%-51.42%-41.41%-73.00%-41.51%-31.75%
Upgrade
Earnings Yield
-121.63%-60.21%-38.57%-42.83%-24.16%-13.79%
Upgrade
FCF Yield
-97.10%-48.07%-26.63%-31.97%-24.98%-7.56%
Upgrade
Buyback Yield / Dilution
-23.18%-23.18%-31.11%-5.72%-11.36%-192.32%
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q